Fundraising FoxRxsight
NASDAQ: RXSTPasadena, US · Incorporated in Delaware · 9 known investors
Find your way into Rxsight
Sign up to see every warm intro you have to Rxsight
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rxsight team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RxSight is an ophthalmic medical technology company that developed the Light Adjustable Lens (LAL), an intraocular lens that can be customized after cataract surgery to optimize a patient's vision. It serves cataract surgeons and their patients in the premium cataract surgery market.
Founders & leadership
Board
Investors · 9
How we know: Flying L Partners's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · Not right? Tell us
How we know: H.I.G. HealthBridge Partners's portfolio page · Not right? Tell us
How we know: Longitude Capital's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: RA Capital's portfolio page · the S-1 prospectus · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$62.7M disclosed across 2 rounds · 2012–2017
▶$50MraisedApr 2017 · 62 investors · Other Health CareRule 506(b)
- William LinkDirector
- Juliet BakkerDirector
- J. Andy CorleyDirector
- Shelley ThunenExecutive Officer
- Ron KurtzExecutive Officer, Director
- Dan SchwartzDirector
- Bruce RobertsonDirector
- Chris CoxDirector
- Werner WolfenDirector
- Offering amount
- $77.5M
- Amount sold
- $50M
- First sale
- Feb 2017
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$12.7MraisedMar 2014 · 45 investors · Other TechnologyRule 506(b)
- Joseph DevivoDirector
- James N. AdlerDirector
- Robert H. GrubbsDirector
- Werner F. WolfenDirector
- D. Verne SharmaExecutive Officer, Director
- Javier Perez-SalaDirector
- Richard DrinkwardExecutive Officer
- Jan BonelDirector
- Daniel M. SchwartzDirector
- Offering amount
- $47M
- Amount sold
- $12.7M
- Minimum investment
- $50K
- Sales commissions
- $450K
- Proceeds to insiders
- $467.5K
- Placement agents
- Piper Jaffray & Co., Brockett Tamny & Co., Incorporated
- First sale
- Oct 2012
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does Rxsight do?
- RxSight is an ophthalmic medical technology company that developed the Light Adjustable Lens (LAL), an intraocular lens that can be customized after cataract surgery to optimize a patient's vision. It serves cataract surgeons and their patients in the premium cataract surgery market.
- Who founded Rxsight?
- Rxsight was founded by Robert H. Grubbs, Daniel M. Schwartz.
- Who are Rxsight's investors?
- Rxsight's investors include Flying L Partners, Foresite Capital, H.I.G. Capital, H.I.G. HealthBridge Partners, Longitude Capital, RA Capital, Visionary Ventures, RxSight and 1 more.
- How much funding has Rxsight raised?
- Rxsight has disclosed $62.7M raised across 2 rounds.
- Where is Rxsight headquartered?
- Rxsight is headquartered in Pasadena, US.